Workflow
Autoscope Technologies Corporation Announces Quarterly Dividend
GlobeNewswire· 2025-02-06 21:10
MINNEAPOLIS, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (“Autoscope”) (OTCQX: AATC) announced today that its Board of Directors has declared a regular quarterly dividend of $0.15 per share of common stock, payable on February 25, 2025 to shareholders of record at the close of business on February 18, 2025. About Autoscope Technologies Corporation Autoscope Technologies Corporation is a global company dedicated to helping improve safety and efficiency for cities and highways by deve ...
GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
GlobeNewswire· 2025-02-06 21:10
2 new ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b also expected by year-end 2025 for GNS561/trametinib in KRAS-mutated cholangiocarcinoma, to support dose selection for Phase 2 Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 6, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improvin ...
F&G Annuities & Life Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
Prnewswire· 2025-02-06 21:10
DES MOINES, Iowa, Feb. 6, 2025 /PRNewswire/ -- F&G Annuities & Life, Inc. (NYSE: FG) ("F&G"), a leading provider of insurance solutions serving retail annuity and life customers and institutional clients, will release fourth quarter and full year 2024 earnings after the close of regular market trading on Thursday, February 20, 2025.A webcast and conference call to discuss the results will follow at 9:00 a.m. Eastern Time on Friday, February 21, 2025. Additional information about the quarterly financial resu ...
Simon Property Group Announces Retirement of Herbert Simon
Prnewswire· 2025-02-06 21:10
INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- The Board of Directors of Simon Property Group, Inc. (NYSE: SPG) today announced that Herbert Simon Chairman Emeritus of the Board of Directors has retired effective February 4, 2025. Herbert Simon stated, "Mel and I started our real estate journey 65 years ago having no idea where it would take us. Simon has grown to be one of the most respected and successful companies in the world. With David's leadership as CEO starting 30 years ago in 1994, I expect that SPG w ...
Mohawk Industries Reports Q4 Results
GlobeNewswire· 2025-02-06 21:10
CALHOUN, Ga., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) today announced fourth quarter 2024 net earnings of $93 million and earnings per share (“EPS”) of $1.48; adjusted net earnings were $123 million, and adjusted EPS was $1.95. Net sales for the fourth quarter of 2024 were $2.6 billion, an increase of 1.0% as reported and a decrease of 1.0% on an adjusted basis versus the prior year. During the fourth quarter of 2023, the Company reported net sales of $2.6 billion, net earnings ...
LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025
GlobeNewswire· 2025-02-06 21:10
SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 27, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, ...
Coca-Cola Consolidated, Inc. To Release Fourth Quarter and Fiscal Year 2024 Results
GlobeNewswire· 2025-02-06 21:10
CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQ: COKE) will issue a news release after the market closes on February 20, 2025 to announce its operating results for the fourth quarter and fiscal year ended December 31, 2024. CONTACTS: Brian K. Little (Media)Scott Anthony (Investors)Vice President, Corporate CommunicationsExecutive Vice President & Chief Financial Officer(980) 378-5537(704) 557-4633Brian.Little@cokeconsolidated.comScott.Anthony@cokeconsolidated.com Ab ...
DTE Energy names Casey Santos to board of directors
GlobeNewswire· 2025-02-06 21:10
Casey Santos DTE Energy names Casey Santos to board of directors Detroit, Feb. 06, 2025 (GLOBE NEWSWIRE) -- DTE Energy (NYSE: DTE) has named Casey Santos to its board of directors effective Feb. 6. Santos recently joined Caliber as chief technology officer. Prior to Caliber, Santos led Asurion’s global technology and procurement teams as their chief information officer. She has more than 25 years of experience as an executive leader, an independent board director for public and private organizations, an ...
Pixalate’s January 2025 UK Publisher Rankings: Top Mobile ‘Sports’ Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store
GlobeNewswire· 2025-02-06 21:10
According to Pixalate’s January 2025 rankings, Sky Sports, FotMob - Soccer Live Scores, and Flashscore - Lives Scores were the top three Google Play Store apps within the ‘Sports’ IAB mobile app category for programmatic ad traffic quality in the United KingdomLondon, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Pixalate, a leading global platform for ad fraud protection, privacy, and compliance analytics, today released the United Kingdom January 2025 Top Mobile ‘Sports’ Apps Rankings for Programmatic Advertising Tra ...
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
GlobeNewswire· 2025-02-06 21:06
TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has signed an advisory agreement with Mr. Matthew Azrieli. Mr. Azrieli is a current shareholder of PharmAla Biotech. “Having come to know Matthew well over the past number of months, I believe he will b ...